Daratumumab (DARA) in combination with carfilzomib, lenalidomide, and dexamethasone (KRd) in patients (pts) with newly diagnosed multiple myeloma (MMY1001): An open-label, phase 1b study.
暂无分享,去创建一个
A. Jakubowiak | S. Lonial | A. Chari | B. Weiss | S. Usmani | R. Comenzo | N. Khokhar | K. Wu | P. Doshi | Jianping Wang